Methyl donor deficient diets cause distinct alterations in lipid metabolism but are poorly representative of human NAFLD

Abstract

<b>Background</b>: Non-alcoholic fatty liver disease (NAFLD) is a global health issue. Dietary methyl donor restriction is used to induce a NAFLD/non-alcoholic steatohepatitis (NASH) phenotype in rodents, however the extent to which this model reflects human NAFLD remains incompletely understood. To address this, we undertook hepatic transcriptional profiling of methyl donor restricted rodents and compared these to published human NAFLD datasets. <b>Methods</b>: Adult C57BL/6J mice were maintained on control, choline deficient (CDD) or methionine/choline deficient (MCDD) diets for four weeks; the effects on methyl donor and lipid biology were investigated by bioinformatic analysis of hepatic gene expression profiles followed by a cross-species comparison with human expression data of all stages of NAFLD. <b>Results</b>: Compared to controls, expression of the very low density lipoprotein (VLDL) packaging carboxylesterases ( <i>Ces1d</i>, <i>Ces1f</i>, <i>Ces3b</i>) and the NAFLD risk allele <i>Pnpla3</i> were suppressed in MCDD; with <i>Pnpla3</i> and the liver predominant <i>Ces</i> isoform, <i>Ces3b</i>, also suppressed in CDD. With respect to 1-carbon metabolism, down-regulation of <i>Chka</i>, <i>Chkb</i>, <i>Pcty1a</i>, <i>Gnmt</i> and <i>Ahcy</i> with concurrent upregulation of <i>Mat2a</i> suggests a drive to maintain S-adenosylmethionine levels. There was minimal similarity between global gene expression patterns in either dietary intervention and any stage of human NAFLD, however some common transcriptomic changes in inflammatory, fibrotic and proliferative mediators were identified in MCDD, NASH and HCC. <b>Conclusions</b>: This study suggests suppression of VLDL assembly machinery may contribute to hepatic lipid accumulation in these models, but that CDD and MCDD rodent diets are minimally representative of human NAFLD at the transcriptional level.